<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01543529</url>
  </required_header>
  <id_info>
    <org_study_id>BP28180</org_study_id>
    <nct_id>NCT01543529</nct_id>
  </id_info>
  <brief_title>A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers</brief_title>
  <official_title>A Single Center, Randomized, Double-blind, Single-dose, Four Period, Crossover Study to Investigate Pharmacodynamics and Pharmacokinetics of RO4917838 Alone or With Concomitant Administration of Alcohol in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hoffmann-La Roche</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hoffmann-La Roche</source>
  <brief_summary>
    <textblock>
      This single-center, randomized, double-blind, four-period crossover study will investigate
      the effect of alcohol on the pharmacodynamics and pharmacokinetics of RO4917838 in healthy
      volunteers. Healthy volunteers will receive 4 treatments in a randomized order: single dose
      of RO4917838 and alcohol, RO4917838 and non-alcoholic drink, placebo to RO4917838 and
      alcohol, and placebo to RO4917838 and non-alcoholic drink.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 28, 2012</start_date>
  <completion_date type="Actual">June 4, 2012</completion_date>
  <primary_completion_date type="Actual">June 4, 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of alcohol on pharmacodynamics (Cognitive test battery) of RO4917838</measure>
    <time_frame>Day 1 of each treatment period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of alcohol on pharmacokinetics (Area under the concentration time curve) of RO4917838</measure>
    <time_frame>Days 1, 2, 3, 4, 6, and 8 of each treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety: Incidence of adverse events</measure>
    <time_frame>Approximately 4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Healthy Volunteer</condition>
  <arm_group>
    <arm_group_label>RO4917838 + non-alcoholic drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>RO4917838 + alcohol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>RO4917838 placebo + alcohol</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>RO4917838 placebo + non-alcoholic drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RO4917838</intervention_name>
    <description>Single dose of RO4917838</description>
    <arm_group_label>RO4917838 + non-alcoholic drink</arm_group_label>
    <arm_group_label>RO4917838 + alcohol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to RO4917838</intervention_name>
    <description>Single dose of placebo to RO4917838</description>
    <arm_group_label>RO4917838 placebo + alcohol</arm_group_label>
    <arm_group_label>RO4917838 placebo + non-alcoholic drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alcohol</intervention_name>
    <description>Standard alcoholic drink</description>
    <arm_group_label>RO4917838 + alcohol</arm_group_label>
    <arm_group_label>RO4917838 placebo + alcohol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult healthy volunteers, 18 to 45 years, inclusive

          -  Body Mass Index (BMI) 18 to 30 kg/m2, inclusive

          -  Non-smoker or smoker of fewer than 10 cigarettes per day

          -  Females, who are not menopausal must agree to use two adequate methods of
             contraception

        Exclusion Criteria:

          -  Any current medical condition or disease that would render the volunteer unsuitable
             for the study, or would place the volunteer at undue risk

          -  History of alcoholism

          -  History of drug abuse and/or addiction within one year of study start

          -  History of any significant disease (e.g., cardiovascular, hepatic, renal) or cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Hoffmann-La Roche</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BIOTRIAL</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2012</study_first_submitted>
  <study_first_submitted_qc>February 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2012</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

